In-Person FDA Meeting Scheduled for April 2; New Drug Application Submission Targeted for Mid-2025$17.5 million increase in ...

Cingulate (CING) reported that as of December 31, 2024, the company had approximately $12.2M in cash and cash equivalents, a $12.1M increase ...

March 26, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to ...

March 26, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and ...

March 04, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to ...

Next time you feel an itch, remember that your brain's vast network of neurons informs it whether it is an itch or pain. A ...

Cingulate (NASDAQ:CING – Get Free Report) is expected to release its earnings data before the market opens on Monday, March ...